首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

2077316

新冠病毒檢測試劑盒市場：依產品類型、檢體類型、最終用戶和地區分類

COVID-19 Detection Kits Market, By Product Type, By Specimen Type, By End User, By Geography

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，新冠病毒檢測試劑盒市場規模將達到 47.4 億美元，到 2033 年將達到 56.7 億美元。預計 2026 年至 2033 年的複合年成長率為 2.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	47.4億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	2.60	2033年市場規模預測：	56.7億美元

新冠病毒檢測試劑盒可透過兩種方法識別SARS-CoV-2（新型冠狀病毒）：第一種是RT-PCR檢測，用於檢測病毒本身；第二種是免疫檢測，用於檢測感染後產生的抗體。為防止病毒進一步傳播，世界各國政府和監管機構正致力於進行盡可能多的新冠病毒檢測，導致全球對新冠病毒檢測試劑盒的需求激增。例如，2020年4月4日，英國衛生和社會保障部報告稱，英國國家醫療服務體系（NHS）迄今已進行了約20萬次檢測，使英國的檢測能力從每天5000次提高到1萬次。據同一資訊來源稱，NHS計劃在4月底前將其在英國的拭子檢測能力提高到每天近2.5萬次。因此，預計在預測期內，對新冠病毒檢測需求的成長將推動市場成長。

市場動態

各大公司正積極採取非內部成長策略，例如合作和共同開發，以擴大新冠病毒檢測試劑盒的生產，預計將推動預測期內的市場成長。例如，2020年4月14日，分子診斷公司Co-Diagnostics, Inc.與分子診斷組件供應商Promega Corporation達成合作，擴大其「Logix Smart COVID-19」檢測試劑盒的生產。此次合作將使Co-Diagnostics, Inc.能夠滿足市場對新冠病毒檢測試劑盒的需求，並鞏固其在美國市場的地位。

同樣，2020年4月29日，Centene Corporation與診斷資訊服務供應商Quest Diagnostics合作，擴大其在美國的即時逆轉錄聚合酵素鏈鎖反應（rRT-PCR）COVID-19檢測能力。透過此次合作，Centene將每週向美國10個州或地區的聯邦認證醫療中心（FQHC）分發約25,000份Quest COVID-19檢測試劑盒。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新藥上市和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球 COVID-19 檢測試劑盒市場的主要參與者進行了分析：公司概況、財務業績、產品系列、市場佔有率、分銷策略、主要發展、戰略和未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的藥物上市、檢體類型擴展、市場成長和行銷策略做出明智的決策。
這份「全球 COVID-19 檢測試劑盒市場」報告針對產業內的各種相關人員，包括投資者、供應商、製藥製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球 COVID-19 檢測試劑盒市場分析中使用的各種策略矩陣來簡化決策過程。

介紹
市場規模及預測、年成長率（依產品類型分類）
市場規模及預測、年成長率（依檢體類型分類）
市場規模及預測、年成長率（依最終用戶分類）。
按國家/地區分類的市場規模和預測，以及按國家/地區分類的年成長率
- 美國
- 加拿大

第15章歐洲

介紹
市場規模及預測、年成長率（依產品類型分類）
市場規模及預測、年成長率（依檢體類型分類）
市場規模及預測、年成長率（依最終用戶分類）。
按國家/地區分類的市場規模和預測，以及按國家/地區分類的年成長率
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家

第16章亞太地區

介紹
市場規模及預測、年成長率（依產品類型分類）
市場規模及預測、年成長率（依檢體類型分類）
市場規模及預測、年成長率（依最終用戶分類）。
按國家/地區分類的市場規模和預測，以及按國家/地區分類的年成長率
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區

第17章拉丁美洲

介紹
市場規模及預測、年成長率（依產品類型分類）
市場規模及預測、年成長率（依檢體類型分類）
市場規模及預測、年成長率（依最終用戶分類）。
按國家/地區分類的市場規模和預測，以及按國家/地區分類的年成長率
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲

第18章中東

介紹
市場規模及預測、年成長率（依產品類型分類）
市場規模及預測、年成長率（依檢體類型分類）
市場規模及預測、年成長率（依最終用戶分類）。
按國家/地區分類的市場規模和預測，以及按國家/地區分類的年成長率
- GCC
- 以色列
- 其他中東國家

第19章非洲

介紹
市場規模及預測、年成長率（依產品類型分類）
市場規模及預測、年成長率（依檢體類型分類）
市場規模及預測、年成長率（依最終用戶分類）。
市場規模及預測（按國家/地區分類）、年成長率（按國家/地區分類）
- 北非
- 中非
- 南非

第20章競爭格局

公司簡介
- Co-Diagnostics, Inc.
- F. Hoffmann-La Roche AG
- Siemens Healthineers AG
- Thermo Fisher Scientific
- Abbott Laboratories
- BGI
- Cepheid Inc.
- BioFire Diagnostics
- GenMark Diagnostics
- Qiagen
- Quidel Corporation
- Randox Laboratories Ltd.
- SD Biosensor, INC.
- Shenzhen Bioeasy BIoTechnology Co., Ltd.
- Seegene Inc.
- JOYSBIO BIoTechnology
- Cipla Limited
- Bione
- Virax Biolabs Group Limited
- SD BioSensor, Inc.
- NanoSpot.ai
- J. Mitra & Co. Pvt. Ltd.
- Genes2Me
- Ubio BIoTechnology Systems Pvt Ltd
- Bharat BIoTech
- Gennova Biopharmaceuticals
- QRX Pharma
- Angstrom BIoTech Pvt. Ltd.
- Detect, Inc.

第21章

參考
調查方法

簡介目錄

Product Code: CMI3839

COVID-19 Detection Kits Market is estimated to be valued at USD 4.74 Bn in 2026 and is expected to reach USD 5.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.74 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	2.60%	2033 Value Projection:	USD 5.67 Bn

COVID-19 detection kits can identify the SARS-CoV-2 or coronavirus through two methods. The first method is the RT-PCR method in which the presence of the virus itself is detected and the second is an immunoassay test which detects antibodies produced in response to the infection. In order to prevent further spread of the virus, governments and regulatory authorities all over the world are focusing on conducting maximum number of COVID-19 detection tests which has led to a high demand for COVID-19 detection kits globally. For instance, on April 04, 2020, the Department of Health and Social Care, UK, reported that National Health Service has conducted around 200,000 tests so far and has also scaled up the testing capacity from 5,000 to 10,000 tests per day in the U.K. According to the same source, the National Health Service is planning to increase the capacity to nearly 25,000 swab tests per day by the end of April in the U.K. Hence, the increasing demand for COVID-19 detection is expected to boost the market growth during the forecast period.

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to increase the production of COVID-19 tests is expected to propel the market growth during the forecast period. For instance, on April 14, 2020, Co-Diagnostics, Inc., a molecular diagnostics company, collaborated with Promega Corporation, a provider of molecular diagnostic components, to amplify the production of Logix Smart COVID-19 tests. This collaboration will allow Co-Diagnostics, Inc. to meet the demand for COVID-19 tests and strengthen its presence in the U.S.

Similarly, on April 29, 2020, Centene Corporation collaborated with Quest Diagnostics, provider of diagnostic information services to increase availability of real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in the U.S. Through this collaboration, Centene will distribute around 25,000 Quest COVID-19 test kits every week to Federally Qualified Health Centers (FQHCs) in ten states or districts across the U.S.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global COVID-19 detection kits market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Co-Diagnostics, Inc F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Abbott Laboratories, BGI, Cepheid Inc, BioFire Diagnostics, GenMark Diagnostics, Qiagen, Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, INC., Shenzhen Bioeasy Biotechnology Co., Ltd., and Seegene Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, Specimen Type up-gradation, market expansion, and marketing tactics
The global COVID-19 detection kits market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 detection kits market

Detailed Segmentation:

Global COVID-19 detection kits Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes
Global COVID-19 detection kits Market, By Specimen Type (Revenue, USD Bn, 2021 - 2033)
Nasopharyngeal swab
Oropharyngeal swab
Nasal swab
Sputum
Others
Global COVID-19 detection kits Market, By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Diagnostic centers
Others
Global COVID-19 detection kits Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Product Type
  - RT-PCR Assay Kits
  - Immunoassay Test Strips/Cassettes
- By Specimen Type:
  - Nasopharyngeal swab
  - Oropharyngeal swab
  - Nasal swab
  - Sputum
  - Others
- By End User:
  - Hospitals
  - Diagnostic centers
  - Others
- By Country:
  - U.S.
  - Canada
Latin America
- By Product Type
  - RT-PCR Assay Kits
  - Immunoassay Test Strips/Cassettes
- By Specimen Type:
  - Nasopharyngeal swab
  - Oropharyngeal swab
  - Nasal swab
  - Sputum
  - Others
- By End User:
  - Hospitals
  - Diagnostic centers
  - Others
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Product Type
  - RT-PCR Assay Kits
  - Immunoassay Test Strips/Cassettes
- By Specimen Type:
  - Nasopharyngeal swab
  - Oropharyngeal swab
  - Nasal swab
  - Sputum
  - Others
- By End User:
  - Hospitals
  - Diagnostic centers
  - Others
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Product Type
  - RT-PCR Assay Kits
  - Immunoassay Test Strips/Cassettes
- By Specimen Type:
  - Nasopharyngeal swab
  - Oropharyngeal swab
  - Nasal swab
  - Sputum
  - Others
- By End User:
  - Hospitals
  - Diagnostic centers
  - Others
- By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Product Type
  - RT-PCR Assay Kits
  - Immunoassay Test Strips/Cassettes
- By Specimen Type:
  - Nasopharyngeal swab
  - Oropharyngeal swab
  - Nasal swab
  - Sputum
  - Others
- By End User:
  - Hospitals
  - Diagnostic centers
  - Others
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Product Type
  - RT-PCR Assay Kits
  - Immunoassay Test Strips/Cassettes
- By Specimen Type:
  - Nasopharyngeal swab
  - Oropharyngeal swab
  - Nasal swab
  - Sputum
  - Others
- By End User:
  - Hospitals
  - Diagnostic centers
  - Others
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Co-Diagnostics, Inc*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
Hoffmann-La Roche AG
Siemens Healthineers AG
Thermo Fisher Scientific
Abbott Laboratories
BGI
Cepheid Inc
BioFire Diagnostics
GenMark Diagnostics
Qiagen
Quidel Corporation
Randox Laboratories Ltd.
SD Biosensor, INC.
Shenzhen Bioeasy Biotechnology Co., Ltd.
Seegene Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Specimen Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. RT-PCR Assay Kits

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

5. Immunoassay Test Strips/Cassettes

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

6. Nasopharyngeal swab

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

7. Oropharyngeal swab

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

8. Nasal swab

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

9. Sputum

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

10. Others

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Segment Trends

11. Hospitals

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

12. Diagnostic centers

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

13. Others

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

14. North America

Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- U.S.
- Canada

15. Europe

Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe

16. Asia Pacific

Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific

17. Latin America

Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America

18. Middle East

Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East

19. Africa

Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021-2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa

20. Competitive Landscape

Company Profiles
- Co-Diagnostics, Inc.*
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- F. Hoffmann-La Roche AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Siemens Healthineers AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- BGI
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cepheid Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- BioFire Diagnostics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- GenMark Diagnostics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Qiagen
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Quidel Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Randox Laboratories Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- SD Biosensor, INC.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Shenzhen Bioeasy Biotechnology Co., Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Seegene Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- JOYSBIO Biotechnology
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cipla Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bione
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Virax Biolabs Group Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- SD BioSensor, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- NanoSpot.ai
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- J. Mitra & Co. Pvt. Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genes2Me
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ubio Biotechnology Systems Pvt Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bharat Biotech
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gennova Biopharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- QRX Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Angstrom Biotech Pvt. Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Detect, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies